Duloxetine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Duloxetine
HEALTH CANADA PATENTS

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Duloxetine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

108 API Suppliers, 45 USDMF, 28 CEP/COS, 13 JDMF, 19 EU WC, 26 KDMF, 18 NDC API, 58 Listed Suppliers, $ API Reference Price

108 API Suppliers
45 USDMF
28 CEP/COS
13 JDMF
19 EU WC
26 KDMF
18 NDC API
58 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

30 API Suppliers

30 API Suppliers

FINISHED DOSAGE FORMULATIONS

584 FDF Dossiers, 98 FDA Orange Book, 282 Europe, 44 Canada, 14 Australia, 30 South Africa, 116 Listed Dossiers

584 FDF Dossiers
98 FDA Orange Book
282 Europe
44 Canada
14 Australia
30 South Africa
116 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 20MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 30MG BASE
CAPSULE, DELAYED REL PELLETS;ORAL - EQ 60MG BASE

RELATED EXCIPIENT COMPANIES

2 Evonik, 1 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 15 DKSH, 2 Jai Radhe Sales, 8 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 35 BASF, 1 Clariant, 13 Corel Pharma Chem, 3 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 4 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 11 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 6 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

86 Fillers, Diluents & Binders, 73 Coating Systems & Additives, 40 Direct Compression, 40 Controlled & Modified Release, 35 Solubilizers, 32 Disintegrants & Superdisintegrants, 25 Thickeners and Stabilizers, 25 Granulation, 20 Taste Masking, 20 Topical, 20 Parenteral, 17 Chewable & Orodispersible Aids, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 16 Co-Processed Excipients, 9 Empty Capsules, 8 Emulsifying Agents, 8 API Stability Enhancers, 5 Coloring Agents, 5 Surfactant & Foaming Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules

86 Fillers, Diluents & Binders
73 Coating Systems & Additives
40 Direct Compression
40 Controlled & Modified Release
35 Solubilizers
32 Disintegrants & Superdisintegrants
25 Thickeners and Stabilizers
25 Granulation
20 Taste Masking
20 Topical
20 Parenteral
17 Chewable & Orodispersible Aids
17 Lubricants & Glidants
16 Film Formers & Plasticizers
16 Co-Processed Excipients
9 Empty Capsules
8 Emulsifying Agents
8 API Stability Enhancers
5 Coloring Agents
5 Surfactant & Foaming Agents
4 Rheology Modifiers
4 Vegetarian Capsules

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 50 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
50 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 216 Finished Drug Prices, 14 Annual Reports

2 US Medicaid Prescriptions
216 Finished Drug Prices
14 Annual Reports

MARKET PLACE

23 APIs, 7 FDF Dossiers

23 APIs
7 FDF Dossiers

PATENTS & EXCLUSIVITIES

16 US Patents, 6 Health Canada Patents

16 US Patents
6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 3 USP, 10 Others

3 EDQM
3 USP
10 Others

ANALYTICAL

2 BioAnalytical Methods, 2 Analytical Methods

2 BioAnalytical Methods
2 Analytical Methods

$ API Ref.Price (USD/KG) : 242 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

6 All

01 4Gowling Lafleur Henderson LLP

02 2Blank

filter Patent Reset all filters

6 All

01 21302421

02 22153856

03 22344057

filter Product Reset all filters

6 All

01 4Duloxetine Hydrochloride

02 2Blank

filter Dosage Reset all filters

6 All

01 4Delayed-Release Capsule

02 2Blank

filter Exp Date Reset all filters

6 All

01 22009-06-02

02 22015-07-13

03 22019-09-10

Product Main Page

01

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

PackExpo

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2153856

Filing Date : 1995-07-13

Strength per Unit : 30 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

PackExpo

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2153856

Filing Date : 1995-07-13

Strength per Unit : 60 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2015-07-13

Date Granted : 2005-05-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

PackExpo

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2344057

Filing Date : 1999-09-10

Strength per Unit : 30 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Lafleur Henderson LLP

Duloxetine Hydrochloride

PackExpo

Not Confirmed

Gowling Lafleur Henderson LLP

Canada

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Duloxetine Hydrochloride

Brand Name : CYMBALTA

Patent Number : 2344057

Filing Date : 1999-09-10

Strength per Unit : 60 mg

Dosage Form : Delayed-Release Capsule

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-09-10

Date Granted : 2008-11-18

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Duloxetine Hydrochloride

PackExpo

Not Confirmed

Country

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2009-06-02

Date Granted :

Duloxetine Hydrochloride

Brand Name :

Patent Number : 1302421

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2009-06-02

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

06

Duloxetine Hydrochloride

PackExpo

Not Confirmed

Country

PackExpo

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2009-06-02

Date Granted :

Duloxetine Hydrochloride

Brand Name :

Patent Number : 1302421

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2009-06-02

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?